HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Testosterone treatment and association with thrombin generation and coagulation inhibition in Klinefelter syndrome: A cross-sectional study.

AbstractBACKGROUND:
The background for the increased occurrence of thrombosis seen in Klinefelter syndrome (KS) is unknown. The aim was to compare thrombin generation and coagulation inhibition between men with KS and controls, and to investigate whether coagulation in KS was associated with testosterone treatment (TT), and as such, measures of androgen action.
METHODS:
Untreated men with KS (U-KS) or testosterone treated men with KS (T-KS) were included. KS groups were matched by age and education to groups of control males with no history of TT. Blood samples were collected after overnight fasting. Low tissue factor (1pM) thrombin generation was expressed as lag time (min), time to peak (min), peak (nmol/L), and endogenous thrombin potential (nmol/L × min, ETP). Coagulation inhibitors, sex hormones, and haematocrit were measured. Matched groups were compared by Student's t-test or Wilcoxon rank sum test. Among KS, TT status as an outcome predictor was evaluated by linear regression.
RESULTS:
18 U-KS and 27 T-KS with corresponding controls participated. Thrombin generation was not different comparing U-KS and T-KS with respective control groups. Among KS, ETP was lower in T-KS compared with U-KS and inversely associated with testosterone, LH-testosterone ratio and haematocrit.
CONCLUSION:
Neither U-KS nor T-KS expressed a pro-coagulant state compared with controls. Thrombin generation among KS was inversely associated with androgen action and lower in T-KS compared with U-KS. Whether TT is capable of lowering thrombotic risk among men with KS needs to be assessed prospectively.
AuthorsSimon Chang, Daniel Biltoft, Anne Skakkebæk, Jens Fedder, Anders Bojesen, M Vakur Bor, Claus H Gravholt, Anna-Marie B Münster
JournalThrombosis research (Thromb Res) Vol. 182 Pg. 175-181 (Oct 2019) ISSN: 1879-2472 [Electronic] United States
PMID31505312 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier Ltd. All rights reserved.
Chemical References
  • Androgens
  • Testosterone
  • Thrombin
Topics
  • Adolescent
  • Adult
  • Aged
  • Androgens (pharmacology, therapeutic use)
  • Blood Coagulation (drug effects)
  • Cross-Sectional Studies
  • Humans
  • Klinefelter Syndrome (blood, drug therapy, metabolism)
  • Male
  • Middle Aged
  • Testosterone (pharmacology, therapeutic use)
  • Thrombin (metabolism)
  • Thrombosis (blood, etiology, metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: